Antiviral drugs

Specificity Reacts with Enterovirus 71. Neutralizes enterovirus 71 BrCr strain at a titer of less than 1:14.

Immunogen Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 495 of Envelope protein (Dengue virus 2) according to NP_739583 Application Suggested starting dilutions are as follows: ICC/IF:

Anti-EPS8L1 EPS8-like 1, 100ul UN 1687 6.1 PG2

Anti-EPS8L1 EPS8-like 1, 100ul UN 1687 6.1 PG2

Anti-EPS8L1 EPS8-like 1, 25ul UN 1687 6.1 PG2

Anti-EPS8L1 EPS8-like 1, 25ul UN 1687 6.1 PG2

Anti-EPS8L2 EPS8-like 2, 100ul UN 1687 6.1 PG2

Anti-EPS8L2 EPS8-like 2, 25ul UN 1687 6.1 PG2

Anti-ERBB3 v-erb-b2 avian erythroblastic leukemia viral onco

Anti-ERBB3 v-erb-b2 avian erythroblastic leukemia viral onco

General description v-ErbB was identified as the viral counterpart of the EGF Receptor, and its relatives have adopted this nomenclature (or the HER nomenclature for human proteins). These proteins are activated by Heregulin, Neuregulin and

Anti-ERBB4 v-erb-b2 avian erythroblastic leukemia viral onco